Hypertension is a major independent risk factor worldwide for adverse fatal or nonfatal
cardiovascular (CV) events, such as myocardial infarction, stroke, and heart failure. Each …

BACKGROUND Despite an association between visit-to-visit blood pressure (BP) variability
(VV-BPV) and cardiovascular (CV) outcomes, many studies performed during the past 4 …

BACKGROUND Recent reports have linked variability in visit-to-visit systolic blood pressure
(SBP) to risk of mortality and stroke, independent of the effect of mean SBP level. This study …

In recent clinical investigations, visit‐to‐visit systolic blood pressure (SBP) variability was
proven as a predictor of cardiovascular events and all‐cause mortality. However …

Objective: Clinical cohort studies have reported that visit-to-visit variability (VVV) of blood
pressure (BP) is associated with cardiovascular disease (CVD) or mortality. However, the …

The association between blood pressure variability (BPV) and the risk of all‐cause mortality
and cardiovascular diseases (CVD) is not well understood. The Kailuan study is a …

Background To investigate the relationship between baseline systolic blood pressure (SBP)
and visit-to-visit blood pressure variability in a general population. Methods This is a …

Objectives: The current study aims to determine the relationship of long-term visit-to-visit
variability of SBP to cardiovascular disease (CVD) in a multiethnic primary care setting …

Large blood pressure (BP) variability contributed to subclinical brain disease thus may be
implicated in the development of cardiovascular disease (CVD). This study included 64,810 …

Background There is a paucity of evidence regarding the association between visit‐to‐visit
blood pressure variability and residual cardiovascular risk. We aimed to provide relevant …